Example: Heart Attack

Clinical Trials on Thrombocytopenia

Total 710 results

NCT04557735

Not yet recruiting

Study of Ravulizumab in Pediatric Participants With HSCT-TMA

Conditions: Thrombotic Microangiopathy
NCT04547153

Not yet recruiting

LD-FUD for Highly Aggressive Gastric Cancer

Conditions: Gastric Cancer; Bone Marrow Metastasis; Thrombocytopenia
NCT04543279

Not yet recruiting

Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia

Conditions: Myelofibrosis
NCT04543591

Not yet recruiting

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Conditions: Thrombotic Microangiopathy
NCT04528355

Recruiting

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Conditions: Primary Immunodeficiency (PID); Congenital Bone Marrow Failure Syndromes; Inherited Metabolic Disorders (IMD); Hereditary Anemias; Inflammatory Conditions
NCT04529382

Enrolling by invitation

Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia

Conditions: Fetal and Neonatal Alloimmune Thrombocytopenia; Long Term Adverse Effects; Neurodevelopmental Abnormality; Intravenous Immunoglobulin Adverse Reaction
NCT04526886

Not yet recruiting

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Conditions: Colorectal Cancer; Gastric Cancer; Esophageal Cancer; Ampullary Cancer; Small Bowel Cancer; Appendix Cancer
NCT04518475

Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Conditions: Primary Immune Thrombocytopenia (ITP)
NCT04518878

Recruiting

Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

Conditions: Immune Thrombocytopenia
NCT04516837

Recruiting

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Conditions: Immune Thrombocytopenia
NCT04516967

Not yet recruiting

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Conditions: Immune Thrombocytopenia
NCT04482777

Not yet recruiting

IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP

Conditions: ITP
NCT04481282

Recruiting

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04478123

Recruiting

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Conditions: Multiple Myeloma; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; HDT-AHCT
NCT04478227

Recruiting

TPO Use in Children for Hemotopoietic Failure

Conditions: Bone Marrow Failure Disorders; Aplastic Anemia; Thrombocytopenia; Refractory Cytopenia of Childhood; Myelodysplastic Syndrome(MDS)
NCT04463316

Recruiting

GROWing Up With Rare GENEtic Syndromes

Conditions: Prader-Willi Syndrome; PWS-like Syndrome; Silver Russel Syndrome; Congenital Hypopituitarism; Klinefelter (XXY-)Syndrome; Congenital Adrenal Hyperplasia; XXXXY Syndrome; XXYY Syndrome; XXXX Syndrome (Tetra-X Syndrome); Disorders of Sex Development; Turner Syndrome; 46, XY DSD; Tuberous Sclerosis; Neurofibromatosis; Albright Hereditaire Osteodystrofie; Cornelia de Lange Syndrome; Saethre-Chotzen Syndrome; 17p- Deletiesyndrome; VCF Syndrome; POLR3A Mutatie; Ohdo Syndrome; Jacobsen Syndrome / 11 q Syndrome; Myrhe Syndrome; CHARGE Syndrome; 1q25-32 Deletie; Bardet Biedl Syndrome; Rett Syndrome; 22q11 Deletion Syndrome; Allan-Herndon-Dudley Syndrome; Kallmann Syndrome; Rare Bone Disorders; Noonan Syndrome; Williams-Beuren Syndrome
NCT04448873

Recruiting

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Conditions: Kaposiform Hemangioendothelioma; Kasabach-Merritt Syndrome
NCT04437953

Recruiting

Avatrombopag for Thrombocytopenia in People With Cancer

Conditions: Thrombocytopenia; Cancer; Liver Diseases
NCT04428255

Not yet recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Conditions: Primary Immune Thrombocytopenic Purpura
NCT04420494

Recruiting

Umbilical Cord Blood Treatment for Refractory Immune Cytopenia

Conditions: Umbilical Cord Blood; Refractory Immune Cytopenia
NCT04409691

Not yet recruiting

SCMC Trial on KHE With KMP (V.2020)

Conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
NCT04371939

Recruiting

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Conditions: Wiskott-Aldrich Syndrome
NCT04368598

Recruiting

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Conditions: Immune Thrombocytopenia
NCT04348799

Completed

Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia

Conditions: Bronchopulmonary Dysplasia; Thrombocytopenia; Preterm Infant
NCT04350164

Active, not recruiting

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Conditions: Wiskott-Aldrich Syndrome
NCT04346654

Recruiting

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Conditions: Immune Thrombocytopenia (ITP)
NCT04324060

Active, not recruiting

A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia

Conditions: Low/Intermediate Risk-1 MDS
NCT04323748

Not yet recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura
NCT04320225

Not yet recruiting

Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04312789

Recruiting

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Conditions: Platelet Disorder
NCT04311593

Not yet recruiting

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenia
NCT04304820

Recruiting

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Conditions: Severe Aplastic Anemia
NCT04289207

Not yet recruiting

Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04278924

Recruiting

Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/Chronic Primary Immune Thrombocytopenia

Conditions: Primary Immune Thrombocytopenia
NCT04274452

Withdrawn

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia (ITP)
NCT04272970

Enrolling by invitation

Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)

Conditions: Thrombocytopenia; Inherited Platelet Disorder
NCT04268940

Recruiting

Thrombo-Elastography Guided Management of ECMO

Conditions: Extracorporeal Circulation of Blood; Thrombocytopenia
NCT04247906

Available

Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

Conditions: Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
NCT04224688

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04225156

Recruiting

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04226950

Recruiting

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia

Conditions: Essential Thrombocytopenia
NCT04217148

Recruiting

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04214951

Recruiting

A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Conditions: Corticosteroid-resistant or Relapsed ITP
NCT04200456

Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04188379

Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04159064

Completed

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

Conditions: Extracorporeal Circulation; Complications; Coagulation Disorder; Extracorporeal Circulation of Blood; Thrombocytopenia
NCT04155775

Enrolling by invitation

Effects of a Platelet Transfusion Best Practices Alert

Conditions: Thrombocytopenia
NCT04132050

Recruiting

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Conditions: Idiopathic Thrombocytopenic Purpura
NCT04132375

Recruiting

Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS

Conditions: Bloody Diarrhea; STEC, Unspecified; Hemolytic-Uremic Syndrome; Pediatric Kidney Disease
NCT04128358

Not yet recruiting

Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?

Conditions: Idiopathic Thrombocytopenic Purpura

COOKIE SETTINGS

Clinical Trials on Thrombocytopenia